What is Generate Biomedicines, Inc. 's operating income?

Generate Biomedicines, Inc. (GENB) reported operating income of -$64.11M in Q1 2026.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Generate Biomedicines, Inc. GENB Operating Income

Operating Income at other companies

Liberty GlobalLBTYB

$23.8M-60.8%

Mirion TechnologiesMIR

$3.7M-57.5%

Dolby Laboratories, Inc.DLB

$112.95M+4.8%

Moelis & CompanyMC

$40.5M+9.7%

Knife RiverKNF

-$86.23M-4.3%

Portland General ElectricPOR

$107M-36.3%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Net income-$61.4M-47.4%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's operating income?: Generate Biomedicines, Inc. (GENB) reported operating income of -$64.11M in Q1 2026.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.